BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang HW, Pittaluga S, Jaffe ES. Multicentric Castleman disease: Where are we now? Semin Diagn Pathol. 2016;33:294-306. [PMID: 27296355 DOI: 10.1053/j.semdp.2016.05.006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Volkow-Fernández P, Lome-Maldonado C, Quintero-Buenrostro H, Islas-Muñoz B, Cornejo-Juárez P. HIV-associated multicentric Castleman disease: a report of 19 cases at an oncology institution. Int J STD AIDS 2020;31:318-25. [PMID: 32089093 DOI: 10.1177/0956462420905277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Cousin E, Flodrops H, Boyer O, Hogan J, Ruin M, Couderc A, Goujon JM, Taque S. Renal failure in pediatric Castleman disease: Four French cases with thrombotic microangiopathy. Pediatr Blood Cancer 2018;65:e27045. [PMID: 29603588 DOI: 10.1002/pbc.27045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Han EJ, O JH, Jung SE, Park G, Choi BO, Jeon YW, Min GJ, Cho SG. FDG PET/CT Findings of Castleman Disease Assessed by Histologic Subtypes and Compared with Laboratory Findings. Diagnostics (Basel) 2020;10:E998. [PMID: 33255420 DOI: 10.3390/diagnostics10120998] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chauveau B, Le Loarer F, Bacci J, Baylac F, Dubus P, Ling C, Parrens M. [Indolent T-lymphoblastic proliferation in association with localized Castleman disease: A case report]. Ann Pathol 2019;39:29-35. [PMID: 30554835 DOI: 10.1016/j.annpat.2018.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Ewald PW. Ancient cancers and infection-induced oncogenesis. Int J Paleopathol 2018;21:178-85. [PMID: 29778408 DOI: 10.1016/j.ijpp.2017.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lurain K, Yarchoan R, Uldrick TS. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease. Hematol Oncol Clin North Am 2018;32:75-88. [PMID: 29157621 DOI: 10.1016/j.hoc.2017.09.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
7 Piccaluga PP, Weber A, Ambrosio MR, Ahmed Y, Leoncini L. Epstein-Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas. Front Microbiol 2018;9:1233. [PMID: 29937761 DOI: 10.3389/fmicb.2018.01233] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
8 Lomas OC, Streetly M, Pratt G, Cavet J, Royston D, Schey S, Ramasamy K; British Society for Haematology (BSH) Committee. The management of Castleman disease. Br J Haematol 2021. [PMID: 34340261 DOI: 10.1111/bjh.17688] [Reference Citation Analysis]
9 Williams C, Phillips A, Aggarwal V, Slonim LB, Fajgenbaum DC, Karmali R. TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy. Case Rep Oncol 2021;14:1359-65. [PMID: 34720942 DOI: 10.1159/000518079] [Reference Citation Analysis]
10 Nishimura Y, Fajgenbaum DC, Pierson SK, Iwaki N, Nishikori A, Kawano M, Nakamura N, Izutsu K, Takeuchi K, Nishimura MF, Maeda Y, Otsuka F, Yoshizaki K, Oksenhendler E, van Rhee F, Sato Y. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. Am J Hematol 2021;96:1241-52. [PMID: 34265103 DOI: 10.1002/ajh.26292] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Gupta A, Kumar PS, Puri V, Saran RK, Narang P, Chowdhury D. 51-year old man with tingling, burning and progressive limb weakness. Pract Neurol 2018;18:382-8. [PMID: 31091191 DOI: 10.1136/practneurol-2017-001877] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Moutinho A, Cunha RG, Jamal SK, Lisboa MM, Tavares S. Idiopathic Multicentric Hyaline Vascular-Type Castleman Disease. Case Rep Hematol 2021;2021:6620666. [PMID: 33936820 DOI: 10.1155/2021/6620666] [Reference Citation Analysis]
13 Kinugawa Y, Uehara T, Iwaya M, Asaka S, Kobayashi S, Nakajima T, Komatsu M, Yasuo M, Yamamoto H, Ota H. IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung. BMC Pulm Med 2021;21:219. [PMID: 34246246 DOI: 10.1186/s12890-021-01603-6] [Reference Citation Analysis]
14 Barlingay G, Findakly D, Hartmann C, Amar S. The Potential Clinical Benefit of Tocilizumab Therapy for Patients with HHV-8-infected AIDS-related Multicentric Castleman Disease: A Case Report and Literature Review. Cureus 2020;12:e7589. [PMID: 32399323 DOI: 10.7759/cureus.7589] [Reference Citation Analysis]
15 Lee YM, Kim JM, Kim SY. Human Herpes Virus 8/Epstein-Barr Virus-Copositive, Plasmablastic Microlymphoma Arising in Multicentric Castleman's Disease of an Immunocompetent Patient. J Pathol Transl Med 2017;51:99-102. [PMID: 28013535 DOI: 10.4132/jptm.2016.09.30] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
16 Nishimura MF, Igawa T, Gion Y, Tomita S, Inoue D, Izumozaki A, Ubara Y, Nishimura Y, Yoshino T, Sato Y. Pulmonary Manifestations of Plasma Cell Type Idiopathic Multicentric Castleman Disease: A Clinicopathological Study in Comparison with IgG4-Related Disease. J Pers Med 2020;10:E269. [PMID: 33321725 DOI: 10.3390/jpm10040269] [Reference Citation Analysis]
17 Fajgenbaum DC, Wu D, Goodman A, Wong R, Chadburn A, Nasta S, Srkalovic G, Mukherjee S, Leitch H, Jayanthan R, Ferrero S, Sato Y, Schey S, Dispenzieri A, Oksenhendler E, Zinzani PL, Lechowicz MJ, Hoffmann C, Pemmaraju N, Bagg A, Fossa A, Lim MS, van Rhee F; Castleman Disease Collaborative Network Scientific Advisory Board diagnostic criteria international working group and treatment guidelines international working group. Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease. Am J Hematol 2020;95:1553-61. [PMID: 32894785 DOI: 10.1002/ajh.25992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Caroline Ribeiro Sales A, Romão de Souza Junior V, Iglis de Oliveira M, Azevedo Braga Albuquerque C, de Barros Campelo Júnior E, Sérgio Ramos de Araújo P. Multicentric Castleman's disease in human immunodeficiency virus infection: two case reports. J Med Case Rep 2018;12:117. [PMID: 29728131 DOI: 10.1186/s13256-018-1656-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Chisholm KM, Fleming MD. Histologic and Laboratory Characteristics of Symptomatic and Asymptomatic Castleman Disease in the Pediatric Population. Am J Clin Pathol 2020;153:821-32. [PMID: 32112075 DOI: 10.1093/ajcp/aqaa011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Kiguchi T, Sato C, Takai K, Nakai Y, Kaneko Y, Matsuki M. CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman's disease. Clinical Radiology 2017;72:905.e1-5. [DOI: 10.1016/j.crad.2017.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
21 Auten M, Kim AS, Bradley KT, Rosado FG. Human herpesvirus 8-related diseases: Histopathologic diagnosis and disease mechanisms. Semin Diagn Pathol 2017;34:371-6. [PMID: 28502522 DOI: 10.1053/j.semdp.2017.04.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
22 Dai L, Lin Z, Jiang W, Flemington EK, Qin Z. Lipids, lipid metabolism and Kaposi's sarcoma-associated herpesvirus pathogenesis. Virol Sin 2017;32:369-75. [PMID: 29019168 DOI: 10.1007/s12250-017-4027-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 de Campos ECR, Júnior MGA, Winheski MR, Mehanna SH, Cavalcanti MS, Martins R. Retroperitoneal castleman disease mimicking lymph node spread from clear renal cell carcinoma. A case report. Urol Case Rep 2021;34:101503. [PMID: 33304821 DOI: 10.1016/j.eucr.2020.101503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Pribyl K, Vakayil V, Farooqi N, Arora N, Kreitz B, Ikramuddin S, Linden MA, Harmon J. Castleman disease: A single-center case series. Int J Surg Case Rep 2021;80:105650. [PMID: 33631648 DOI: 10.1016/j.ijscr.2021.105650] [Reference Citation Analysis]
25 Wick MR, O’malley DP. Lymphadenopathy associated with IgG4-related disease: Diagnosis & differential diagnosis. Seminars in Diagnostic Pathology 2018;35:61-6. [DOI: 10.1053/j.semdp.2017.11.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
26 Hu C, Zou Y, Pan J, Yang J, Yang T, Tan T, Li J. Analysis of Clinical Characteristics, Pathological Changes and Changes of Interleukin-6 (IL-6) and C-Reactive Protein (CRP) in Children with Castleman's Disease. Med Sci Monit 2020;26:e924783. [PMID: 32873770 DOI: 10.12659/MSM.924783] [Reference Citation Analysis]
27 Yang D, Zhou X, Zhao Y, Cao S, Su A, Zhang X, Xu Y, Zhang X. A rare case of multicentric castleman's disease transforms into multiple myeloma and its successful treatment. Cancer Biol Ther 2018;19:949-52. [PMID: 29580142 DOI: 10.1080/15384047.2018.1456606] [Reference Citation Analysis]
28 Hou T, Dhillon J, Xiao W, Jaffe ES, Sands AM, Neppalli V, Deeb G, Zhang N. TAFRO syndrome: A case report and review of the literature. Hum Pathol (N Y) 2017;10:1-4. [PMID: 31608209 DOI: 10.1016/j.ehpc.2017.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Totonchy J. Extrafollicular activities: perspectives on HIV infection, germinal center-independent maturation pathways, and KSHV-mediated lymphoproliferation. Curr Opin Virol 2017;26:69-73. [PMID: 28779693 DOI: 10.1016/j.coviro.2017.07.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
30 Vasilyev VI, Palshina SG, Pavlovskaya AI, Kokosadze NV, Chaltsev BD, Shornikova LA. [Idiopathic multicentric Castleman's disease]. Ter Arkh 2020;92:78-84. [PMID: 32598779 DOI: 10.26442/00403660.2020.05.000440] [Reference Citation Analysis]
31 Cheng JL, Cui J, Wang Y, Xu ZZ, Liu F, Liang SB, Tian H. Unicentric Castleman disease presenting as a retroperitoneal peripancreatic mass: A report of two cases and review of literature. World J Gastroenterol 2018; 24(34): 3958-3964 [PMID: 30228787 DOI: 10.3748/wjg.v24.i34.3958] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
32 Otani K, Inoue D, Fujikura K, Komori T, Abe-Suzuki S, Tajiri T, Itoh T, Zen Y. Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease. Oncotarget 2018;9:6691-706. [PMID: 29467920 DOI: 10.18632/oncotarget.24068] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
33 Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, Casper C, Dispenzieri A, Fosså A, Kelleher D, Kurzrock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KS, Lim MS. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017;129:1646-1657. [PMID: 28087540 DOI: 10.1182/blood-2016-10-746933] [Cited by in Crossref: 171] [Cited by in F6Publishing: 150] [Article Influence: 42.8] [Reference Citation Analysis]
34 Wu D, Lim MS, Jaffe ES. Pathology of Castleman Disease. Hematol Oncol Clin North Am. 2018;32:37-52. [PMID: 29157618 DOI: 10.1016/j.hoc.2017.09.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
35 Neves B, Raimundo P, Farinha P. Fever and generalised lymphadenopathy in an HIV-positive patient: a diagnostic challenge. BMJ Case Rep 2017;2017:bcr-2017-220740. [PMID: 28814592 DOI: 10.1136/bcr-2017-220740] [Reference Citation Analysis]
36 Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, Vercellino L, Meignin V, Gérard L, Galicier L. The full spectrum of Castleman disease: 273 patients studied over 20 years. Br J Haematol. 2018;180:206-216. [PMID: 29143319 DOI: 10.1111/bjh.15019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 12.8] [Reference Citation Analysis]
37 Mantilla B, Myrian Vinan-Vega, Nugent K, Solis X, Paz P, Mallah H, Makram J, Labib S, Yepes-Hurtado A. A lymphoproliferative pericardial mass. Proc (Bayl Univ Med Cent) 2020;33:660-1. [PMID: 33116350 DOI: 10.1080/08998280.2020.1792750] [Reference Citation Analysis]
38 Nuzhnyi E, Fedotova E, Kovrigina A, Glinkina S, Moskalenko A, Illarioshkin S. Immune-mediated ataxia with cerebellar hemiatrophy and dystonia associated with Castleman disease. Clin Neurol Neurosurg 2021;200:106407. [PMID: 33338826 DOI: 10.1016/j.clineuro.2020.106407] [Reference Citation Analysis]
39 Dunleavy K. Unraveling Castleman: progress in a complex process. Blood 2017;129:1570. [PMID: 28336728 DOI: 10.1182/blood-2017-02-764654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Ducoux G, Guerber A, Durel CA, Asli B, Fadlallah J, Hot A. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients. Am J Case Rep 2020;21:e919536. [PMID: 32249274 DOI: 10.12659/AJCR.919536] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]